ClinicalTrials.gov Requirements Continue To Baffle Firms And Feds Alike
This article was originally published in The Gray Sheet
Executive Summary
Device companies are not the only ones tripped up by the new ClinicalTrials.gov trial registration requirements, as FDA, NIH and others struggle to define what is and is not subject to the law
You may also be interested in...
Unapproved Product Trial Data: To Post Or Not To Post On ClinicalTrials.gov?
Device makers say new clinical trial registration and results reporting requirements should be extended to trials of unapproved products only if the trials were stopped for safety reasons
Unapproved Product Trial Data: To Post Or Not To Post On ClinicalTrials.gov?
Device makers say new clinical trial registration and results reporting requirements should be extended to trials of unapproved products only if the trials were stopped for safety reasons
Final Guidance Names Submissions Subject To ClinicalTrials.gov Certification
Final guidance published Jan. 21 provides answers for device companies still confused about how and when they must certify to FDA that they have registered their clinical trials on ClinicalTrials.gov